Literature DB >> 4049601

Acute oral alkali citrate load in healthy humans--response of blood and urinary citrate, mineral metabolism, and factors related to stone formation.

P O Schwille, J H Weippert, W Bausch, G Rümenapf.   

Abstract

In ten healthy volunteers (male/female = 5/5) the effects of two doses (2.5 and 5.0 g) of orally ingested alkali citrate (AC) on serum citrate, variables of mineral metabolism in serum, the urinary excretion of citrate, sodium and minerals were studied and compared with the effects of an oral vehicle load. Also, phosphate crystalluria and the supersaturation of several stone forming phases in urine were evaluated under all loads. The data allow to conclude that 1) the rise in serum citrate may result from citrate absorbed intestinally under AC; 2) systemic metabolic alkalosis is not detectable with the chosen AC doses but may be reflected by the more alkaline urinary pH and a higher citrate excretion; 3) mineral metabolism, serum ionized calcium, parathormone, calcitonin and urinary cyclic AMP included, are more or less stable under acute loads of AC; 4) postprandial phosphate crystalluria is more pronounced with increasing AC, but despite this the direct correlation with the supersaturation of hydroxyapatite is progressively weakened with both doses AC suggesting that the inhibitory effects of this drug may dominate over its effects upon initiation of precipitation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4049601     DOI: 10.1007/BF00261817

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  19 in total

1.  Modified reagents for determination of urea and ammonia.

Authors:  A L CHANEY; E P MARBACH
Journal:  Clin Chem       Date:  1962-04       Impact factor: 8.327

2.  Role of serum Ca, parathyroid hormone, and NaCl infusion on renal Ca and Na clearances.

Authors:  S G Massry; J W Coburn; L W Chapman; C R Kleeman
Journal:  Am J Physiol       Date:  1968-06

3.  Changes in serum calcium fractions and citrate concentrations during massive blood transfusions and cardiopulmonary bypass.

Authors:  T R Abbott
Journal:  Br J Anaesth       Date:  1983-08       Impact factor: 9.166

4.  Ultrafiltrable serum citrate and the relationship between serum and urinary citrate results in controls and renal calcium stone formers.

Authors:  P O Schwille; D Scholz; K Schwille
Journal:  J Clin Chem Clin Biochem       Date:  1982-04

5.  Determination of citrate with citrate lyase.

Authors:  H Moellering; W Gruber
Journal:  Anal Biochem       Date:  1966-12       Impact factor: 3.365

6.  Precipitation of calcium phosphates from electrolyte solutions. V. The influence of citrate ions.

Authors:  L Brecević; H Füredi-Milhofer
Journal:  Calcif Tissue Int       Date:  1979-10-31       Impact factor: 4.333

7.  Effects of metabolic acidosis and alkalosis on sodium and calcium transport in the dog kidney.

Authors:  R A Sutton; N L Wong; J H Dirks
Journal:  Kidney Int       Date:  1979-05       Impact factor: 10.612

8.  Hypocitraturia in patients with gastrointestinal malabsorption.

Authors:  D Rudman; J L Dedonis; M T Fountain; J B Chandler; G G Gerron; G A Fleming; M H Kutner
Journal:  N Engl J Med       Date:  1980-09-18       Impact factor: 91.245

9.  Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts.

Authors:  K Sakhaee; M Nicar; K Hill; C Y Pak
Journal:  Kidney Int       Date:  1983-09       Impact factor: 10.612

10.  Citrate in urine and serum and associated variables in subgroups of urolithiasis. Results from an outpatient stone clinic.

Authors:  P O Schwille; D Scholz; K Schwille; R Leutschaft; I Goldberg; A Sigel
Journal:  Nephron       Date:  1982       Impact factor: 2.847

View more
  6 in total

1.  Prophylactic and therapeutic properties of a sodium citrate preparation in the management of calcium oxalate urolithiasis: randomized, placebo-controlled trial.

Authors:  Shameez Allie-Hamdulay; Allen L Rodgers
Journal:  Urol Res       Date:  2005-05-04

2.  Urolithiasis research--where is it going?

Authors:  P O Schwille
Journal:  Urol Res       Date:  1985

3.  Fasting gastrinemia and elevated supersaturation with hydroxyapatite of fasting urine--observations in renal calcium stone patients and controls.

Authors:  P O Schwille; G Rümenapf; R Köhler; J H Weippert
Journal:  Urol Res       Date:  1987

4.  Citrate and recurrent idiopathic calcium urolithiasis. A longitudinal pilot study on the metabolic effects of oral potassium citrate administered over the short-, medium- and long-term medication of male stone patients.

Authors:  P O Schwille; U Herrmann; C Wolf; I Berger; R Meister
Journal:  Urol Res       Date:  1992

5.  Ammonium urate urolithiasis in the rat with portocaval shunt--some aspects of mineral metabolism and urine composition.

Authors:  U Linnemann; P Kuch; P O Schwille
Journal:  Urol Res       Date:  1986

Review 6.  Urolithiasis--historical, comparative and pathophysiological aspects: a review.

Authors:  A R Michell
Journal:  J R Soc Med       Date:  1989-11       Impact factor: 18.000

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.